Published in Ann Surg Oncol on June 01, 1999
Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res (2008) 3.24
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol (2012) 1.92
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430. Cancer (2011) 1.66
Current concepts of metastasis in melanoma. Expert Rev Dermatol (2008) 1.34
Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol (2011) 1.29
Pancreatic resection for metastatic melanoma. HPB (Oxford) (2003) 1.04
Jejuno-jejunal invagination due to intestinal melanoma. World J Gastroenterol (2007) 0.99
Surgical resection of malignant melanoma metastatic to the pancreas: case series and review of literature. J Gastrointest Cancer (2012) 0.90
Surgery for gastrointestinal malignant melanoma: experience from surgical training center. World J Gastroenterol (2010) 0.86
Primary small bowel melanoma. A case report and a review of the literature. G Chir (2015) 0.81
Combined endoscopic and laparoscopic approach for palliative resection of metastatic melanoma of the stomach. World J Surg Oncol (2006) 0.80
Duodenal and gallbladder metastasis of regressive melanoma: a case report and review of the literature. J Gastrointest Oncol (2015) 0.79
Direct bony invasion of malignant melanoma. Indian J Orthop (2009) 0.79
Resection of peritoneal metastases causing malignant small bowel obstruction. World J Surg Oncol (2007) 0.76
Infarction and Perforation of the Small Intestine due to Tumor Emboli from Disseminated Rectal Cancer. Gut Liver (2008) 0.75
Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol (1999) 0.75
Capsule endoscopy for management of small bowel melanoma-is it time yet? Gastroenterol Hepatol (N Y) (2012) 0.75
Bifocal metastasis of melanoma to the small intestine from an unknown primary with intestinal obstruction - case report. Contemp Oncol (Pozn) (2013) 0.75
Ocular melanoma metastasizing to intra-abdominal lymph nodes. Case Rep Surg (2013) 0.75
Bleeding per rectum in a patient with an amputated finger. Saudi J Gastroenterol (2009) 0.75
Gastrointestinal bleeding as presentation of small bowel metastases of malignant melanoma: Is surgery a good choice? Int J Surg Case Rep (2014) 0.75
A woman with anemia and a small-bowel obstruction. CMAJ (2004) 0.75
Short length of stay and rapid recovery to normal function after surgery for metastatic melanoma to abdominal and retroperitoneal viscera. J Surg Oncol (2009) 0.75
Predominant sarcomatoid carcinoma of the lung concurrent with jejunal metastasis and leukocytosis. Rare Tumors (2010) 0.75
[Secondary tumors of the gastrointestinal tract]. Pathologe (2012) 0.75
Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimen. Eur Radiol (2016) 0.75
Malignant melanoma metastasis to the colon: a curable lesion. Tech Coloproctol (2014) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91
Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87
Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1984) 2.74
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
Patterns of detection in patients with cutaneous melanoma. Cancer (2000) 1.97
Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72
A randomised comparison of two intranasal dexmedetomidine doses for premedication in children. Anaesthesia (2012) 1.56
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients. Ann Surg Oncol (2009) 1.50
The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg (1996) 1.50
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Clin Cancer Res (2000) 1.48
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. Breast Cancer Res Treat (2001) 1.46
Surgical oncology fellowship: viable pathway to academic surgery? Ann Surg Oncol (1999) 1.46
Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg (1999) 1.45
Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol (1999) 1.44
The malignant nature of papillary and cystic neoplasm of the pancreas. Cancer (1991) 1.42
The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery. Cancer J Sci Am (2006) 1.38
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
Desmoplastic small round cell tumors: prognostic indicators and results of surgical management. Ann Surg Oncol (1998) 1.35
Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer (1997) 1.31
A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J (2009) 1.28
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine (1994) 1.28
Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol (1999) 1.26
Melanoma metastatic to stomach, small bowel, or colon. Am J Surg (1991) 1.24
Surgical management of Merkel cell carcinoma. Ann Surg (1999) 1.21
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. J Clin Oncol (1995) 1.17
Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease. Int J Tuberc Lung Dis (2010) 1.11
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol (2001) 1.10
GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res (1995) 1.09
The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib. Oncologist (2011) 1.05
Native cellular fluorescence of neoplastic upper aerodigestive mucosa. Arch Otolaryngol Head Neck Surg (1995) 1.05
Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer (2011) 1.01
Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg (1995) 1.00
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response. J Clin Oncol (1995) 1.00
Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg (1999) 0.98
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease. Invest New Drugs (2012) 0.98
Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy. J Clin Oncol (1999) 0.97
Hepatic metastases from soft-tissue sarcoma. Ann Surg (1995) 0.96
The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: a double-blind placebo-controlled randomized trial with immunological monitoring. Ann Oncol (2011) 0.96
Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer (2001) 0.95
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Inst (1995) 0.95
Major amputation for advanced malignant melanoma. Surg Gynecol Obstet (1989) 0.94
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study. J Clin Oncol (1999) 0.94
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol (2006) 0.93
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer. J Clin Oncol (1996) 0.92
Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol (2000) 0.91
Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg (1990) 0.91
Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant. Clin Cancer Res (1996) 0.91
Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice. Int J Oncol (1998) 0.88
Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia. Clin Cancer Res (2000) 0.87
Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg (1992) 0.86
Computed tomography in evaluation of patients with stage III melanoma. Ann Surg Oncol (1997) 0.86
Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. Cancer Res (1990) 0.85
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer. Semin Oncol (1993) 0.85
Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer. Blood (1994) 0.85
Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. Ann Oncol (2010) 0.85
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer. Clin Cancer Res (1995) 0.85
Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies. Cancer Immunol Immunother (1997) 0.84
Analysis of longitudinal data with unmeasured confounders. Biometrics (1991) 0.84
Indications for and efficacy of splenectomy for haematological disorders. Br J Surg (2013) 0.83
Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. J Nucl Med (1992) 0.82
Melanoma. A multidisciplinary approach for the general surgeon. Surg Clin North Am (2000) 0.82
Prognosis of thick cutaneous melanoma. J Am Coll Surg (1999) 0.81
Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells. Clin Cancer Res (1997) 0.81
Role of elective lymph node dissection in melanoma. Semin Surg Oncol (1998) 0.81
Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol (2001) 0.80
Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol (2013) 0.80
Sentinel lymph node evaluation in melanoma. Arch Dermatol (1997) 0.79
An exploratory study of frequent pain measurement in a cancer clinical trial. Qual Life Res (1996) 0.79
Focal nodular hyperplasia of the liver. Surg Gynecol Obstet (1990) 0.78
Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial. Cancer Res (1994) 0.78
Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. Eur J Surg Oncol (2012) 0.78
Reverse transcriptase polymerase chain reaction (RT-PCR) detection of melanoma-related transcripts in the peripheral blood and bone marrow of patients with malignant melanoma. What have we learned? Recent Results Cancer Res (2001) 0.77
Staging work-up and post-treatment surveillance of patients with melanoma. Clin Plast Surg (2000) 0.77
Peritoneovenous shunting for nongynecologic malignant ascites. Cancer (2001) 0.77
Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell. Oncogene (1993) 0.77
Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report. J Natl Cancer Inst Monogr (1993) 0.77
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report. Ann N Y Acad Sci (1993) 0.77
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma. Cancer (1995) 0.76
Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil). Cancer Res (1997) 0.76
Merkel cell carcinoma. Aust N Z J Surg (1999) 0.76
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195. Leukemia (1995) 0.75
The "true" sentinel lymph node: in search of an operational definition of a biological phenomenon. Ann Surg Oncol (2001) 0.75
Timing of radiotherapy in the treatment of early-stage breast cancer. J Clin Oncol (1993) 0.75
Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study. Clin Cancer Res (1999) 0.75
Phase II trial of carboplatin and etoposide in metastatic breast cancer. Cancer (1993) 0.75
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer. Clin Cancer Res (1999) 0.75
[Nonchromaffin paraganglioma of the orbit--a case report and review of the literature]. Zhonghua Zhong Liu Za Zhi (1984) 0.75
Lymphatic mapping in the management of melanoma in children. Pediatr Dermatol (1999) 0.75